Copyright
©The Author(s) 2016.
World J Gastroenterol. Sep 7, 2016; 22(33): 7463-7477
Published online Sep 7, 2016. doi: 10.3748/wjg.v22.i33.7463
Published online Sep 7, 2016. doi: 10.3748/wjg.v22.i33.7463
Table 1 Review of the biological effects of bile acids
Ref. | Year | Cell/tissue | Bile acid | Dose | Time | Biological effect |
Jean-Louis et al[90] | 2006 | HCT 116 | DCA | 500 μmol/L | 5, 15, 30 min | Cholesterol aggregation at membrane |
1, 2, 4 h | ||||||
DCA | 500 μmol/L | 1 h | Internalization of caveolin-1 | |||
Hirano et al[92] | 1991 | Gastric mucosal primary culture | DCA | 30 min | PKC activation | |
DeRubertis et al[93] | 1987 | Colonic epithelial cells | DCA | DAG ↑ | ||
Takano et al[94] | 1984 | Colonic epithelial cells | DCA | 2 d | DNA ↑ | |
ODC ↑ | ||||||
Magnuson et al[95] | 1994 | In vivo | CA | 2% in diet | 18 wk | Apoptosis ↓ |
Garewal et al[96] | 1996 | Biopsies | DCA | 1 mmol/L | 30 °C 3 h | Apoptosis ↓ |
Tucker et al[97] | 2004 | BxPC3 | CDCA, DCA | 100 μmol/L | 6-12 h | COX-2 ↑ |
SU86.86 | PGE-2 ↑ | |||||
Glinghammar et al[98] | 2001 | HCT 116 | Tauro-CDCA | 200-1200 μmol/L | 15 h | AP-1 ↑, COX-2 ↑, PKC(+), P38(+) |
DCA, CDCA, CA | 250 μmol/L | |||||
Butyric acid | 0.1-4 mmol/L | |||||
HT 29 | DCA | 500 μmol/L | 24 h | COX-2 ↑, PCNA ↑ | ||
Raufman et al[100] | 2015 | In vivo (Asbt-deficient) | Aberrant crypt foci | |||
Cheng et al[101] | 2007 | H508 | DCT | 50 μmol/L | 24 h | MMP ↑ |
Kitamura et al[104] | 2015 | Primary culture (BK5 erbB2 mice) | TCDC | 100 μmol/L | 72 h | Cell proliferation ↑, EGFR MAPK Cyclin D1 ↑ |
Sk-Ch-A-1 | TCDC | 10-200 μmol/L | 72 h | Cell viability ↑ | ||
CDCA, DCA, TC, TDC | 0.5 mmol/L | 30 min | p-erbB2, p-EGFR, p-MAPK, p-Akt ↑ | |||
TCDC | 500 μmol/L | 3 h | HB-EGF ↑ | |||
TCDC | 200 μmol/L | 60 min | TACE activity ↑ | |||
In vivo (BK5 erbB2 mice) | TCDC | 2.5 mmol/L 200 μL | Twice/wk for 20 wk | Skin tumor ↑ | ||
Qiao et al[105] | 2001 | hepatocytes | DCA | 50 μmol/L | 5 min | EGFR/Ras/MAPK activation |
Rao et al[106] | 2002 | Primary rat hepatocytes | TDCA, TCA, DCA | 50 μmol/L | 20 min | p-raf-1↑, MEK ↑, ERK ↑ |
Nagathihalli et al[5] | 2014 | HCT116, HCA-7, BxPC3, AsPC-1, Capan 2 | DCA | 300 μmol/L | 4 h-6 h | TACE co-localization, TGF-α mRNA ↑ |
- Citation: Feng HY, Chen YC. Role of bile acids in carcinogenesis of pancreatic cancer: An old topic with new perspective. World J Gastroenterol 2016; 22(33): 7463-7477
- URL: https://www.wjgnet.com/1007-9327/full/v22/i33/7463.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i33.7463